통합검색
내가 찾은 검색어
'Synergistic activity' 에 대한 통합검색결과 88건입니다.
한빛사88건
-
A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells
- J. Exp. Clin. Cancer Res. Mar 06 2025, 44 (1) | https://doi.org/10.1186/s13046-025-03351-5
- 2025.03
- 의약학
-
Development of a deep neural network model based on high throughput screening data for predicting synergistic estrogenic activity of binary mixtures f
- J. Hazard. Mater. Feb 22 2025, 489 S0304-3894(25)00564-3 | https://doi.org/10.1016/j.jhazmat.2025.137650
- 2025.02
- 바이오·의료융합
-
Fc-competent TIGITx4-1BB bispecific antibody exerts potent long-lasting antitumor activity by potentiating CD8+ T cell activity and Fcγ receptor-medi
- J. Immunother. Cancer Feb 25 2025, 13 (2) e010728 | https://doi.org/10.1136/jitc-2024-010728
- 2025.02
- 의약학
-
Perfluorocarbon-polyepinephrine core-shell nanoparticles as a near-infrared light activatable theranostic platform for bimodal imaging-guided photothe
- Theranostics Published 2025-1-1; 15(3):1077-1 | doi:10.7150/thno.10274
- 2025.01
- 바이오·의료융합
-
A novel ADP-directed chaperone function facilitates the ATP-driven motor activity of SARS-CoV helicase
- Nucleic Acids Res. Jan 24 2025, 53 (3) gkaf034 | https://doi.org/10.1093/nar/gkaf034
- 2025.01
- 생명과학
-
Metal- and covalent-organic framework-based drug delivery systems: Applications to control cell functions
- Coord. Chem. Rev. Available online 16 December 2024 | https://doi.org/10.1016/j.ccr.2024.216400
- 2024.12
- 바이오·의료융합
-
Emodin disrupts the KITENIN oncogenic complex by binding ErbB4 and suppresses colorectal cancer progression in dual blockade with KSRP-binding compoun
- Phytomedicine Available online 10 November 2024, 156247 | https://doi.org/10.1016/j.phymed.2024.156247
- 2024.11
- 의약학
-
Arenicolide Family Macrolides Provide a New Therapeutic Lead Combating Multidrug-resistant Tuberculosis
- Angew. Chem.-Int. Edit. Oct 14 2024, | https://doi.org/10.1002/anie.202412994
- 2024.10
- 의약학
-
Cryo-Nanocatalyst Enhances Therapeutic Efficacy of Cryo-Immunotherapy through Necroptosis and Local Delivery of Programmed Death-Ligand 1 Inhibitors
- ACS Nano Aug 22 2024, | https://doi.org/10.1021/acsnano.4c05809
- 2024.08
- 바이오·의료융합
-
The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate-resistant HER2-overex
- J. Exp. Clin. Cancer Res. Aug 21 2024, 43 (1) 236 | https://doi.org/10.1186/s13046-024-03143-3
- 2024.08
-
Ultrahigh peroxidase-like catalytic performance of Cu-N4 and Cu-N4S active sites-containing reduced graphene oxide for sensitive electrochemical biose
- Biosens. Bioelectron. Jul 01 2024, 255 S0956-5663(24)00264-1 | https://doi.org/10.1016/j.bios.2024.116259
- 2024.07
- 바이오·의료융합
-
Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma
- Mol. Cancer Jul 04 2024, 23 (1) | https://doi.org/10.1186/s12943-024-02031-w
- 2024.07
- 생명과학
-
Preclinical efficacy of potent and selective menin-KMT2A inhibitor JNJ-75276617 in KMT2A- and NPM1-altered leukemias
- Blood Jun 21 2024, blood.2023022480 | https://doi.org/10.1182/blood.2023022480
- 2024.06
-
Exploring the therapeutic potential of endolysin CD27L_EAD against Clostridioides difficile infection
- Int. J. Antimicrob. Agents May 27 2024, S0924-8579(24)00140-7 | https://doi.org/10.1016/j.ijantimicag.2024.107222
- 2024.05
- 바이오·의료융합
-
Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy
- J. Nanobiotechnol. Mar 13 2024, 22 (1) 109 | https://doi.org/10.1186/s12951-024-02314-w
- 2024.03
- 바이오·의료융합
-
Synergistic toxicity with copper contributes to NAT2-associated isoniazid toxicity
- Exp. Mol. Med. Mar 01 2024, | https://doi.org/10.1038/s12276-024-01172-8
- 2024.03
-
rhIL-7-hyFc and hIL-2/TCB2c combination promotes an immune-stimulatory tumor microenvironment that improves antitumor efficacy of checkpoint inhibitor
- J. Immunother. Cancer Mar 12 2024, 12 (3) e008001 | https://doi.org/10.1136/jitc-2023-008001
- 2024.03
- 생명과학
-
Discovery of a novel potent EGFR inhibitor against EGFR activating mutations and on-target resistance in NSCLC
- Clin. Cancer Res. Feb 08 2024, | https://doi.org/10.1158/1078-0432.CCR-23-2951
- 2024.02
- 의약학
-
PD-1H/VISTA mediates immune evasion in acute myeloid leukemia
- J. Clin. Invest. Dec 07 2023, e164325 | https://doi.org/10.1172/JCI164325
- 2023.12
-
Molecular Masking of Synthetic Immunomodulator Evokes Antitumor Immunity with Reduced Immune Tolerance and Systemic Toxicity by Temporal Activity Reco
- Adv. Mater. Oct 30 2023, | https://doi.org/10.1002/adma.202309039
- 2023.10
- 바이오·의료융합
